Iveda Solutions, Inc. — Form 10-Q Summary
Business Context and Reporting Period
Quarterly report for the period ended September 30, 2022. Iveda provides AI-enabled video analytics, video surveillance, IoT devices and platforms, smart power technology, and related services. Operations are conducted primarily through its Taiwan subsidiary, which provides surveillance-system integration, engineering, sourcing and research and development. The company sells hardware, project installations and recurring software or licensing services to municipalities, commercial customers, distributors, integrators and service providers.
The company is a smaller reporting company. Common stock and warrants trade on Nasdaq under IVDA and IVDAW. Common shares outstanding were 14,966,739 as of November 10, 2022, after a one-for-eight reverse stock split effective March 31, 2022.
Financial Performance and Position
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Total revenue | $1.47 million in 2022 versus $0.41 million in 2021 | $2.35 million in 2022 versus $1.30 million in 2021 |
| Equipment sales | $1.36 million versus $0.30 million | $2.14 million versus $1.08 million |
| Service revenue | $0.10 million versus $0.11 million | $0.21 million versus $0.22 million |
| Gross profit | $0.35 million versus $0.27 million | $0.68 million versus $0.52 million |
| Gross margin | 24% versus 67% | 29% versus 40% |
| Operating expenses | $1.03 million versus $0.70 million | $3.07 million versus $2.04 million |
| Loss from operations | $0.68 million versus $0.42 million | $2.39 million versus $1.52 million |
| Net loss | $0.67 million versus $0.45 million | $2.40 million versus $1.78 million |
| Basic and diluted loss per share | $0.04 loss versus $0.05 loss | $0.20 loss versus $0.20 loss |
At September 30, 2022, cash and cash equivalents were $10.56 million, restricted cash was $0.12 million, accounts receivable were $0.64 million, inventory was $0.72 million and total current assets were $12.14 million. Total assets were $12.41 million.
Current liabilities were $3.79 million, including $2.14 million of accounts and other payables, $0.30 million due to related parties, $1.24 million of short-term debt and $0.10 million of current long-term debt. Long-term debt was $0.22 million. Total stockholders’ equity was $8.40 million, compared with a deficit of $0.78 million at December 31, 2021. Accumulated deficit was $43.76 million.
Cash used in operating activities was $3.30 million for the first nine months of 2022 versus $1.18 million in the prior-year period. Investing cash use was $0.01 million. Financing activities provided $12.59 million, principally from equity offerings, resulting in a $9.17 million net increase in cash.
Material Changes Versus the Prior Comparable Period
- Nine-month revenue increased 80% to $2.35 million, driven primarily by higher equipment and installation revenue from Iveda Taiwan and Iveda US.
- Third-quarter revenue increased 257%, reflecting a substantial increase in equipment sales; service revenue was essentially unchanged.
- Gross margin declined to 29% for the nine-month period from 40%, and to 24% for the quarter from 67%, because equipment sales represented a larger share of revenue than higher-margin services.
- Operating expenses increased 50% for the nine-month period and 48% for the quarter, primarily from increased U.S. administrative, sales and technical-support personnel and IvedaAI research and development.
- Nine-month operating loss increased 57% and net loss increased 35%, despite revenue growth.
- Other expense improved substantially, from $0.26 million in the prior-year nine-month period to $0.01 million of expense, primarily because most convertible debentures were converted in 2021 and interest income increased.
- Cash increased significantly from the prior year, primarily due to approximately $11.5 million of net proceeds from April and August 2022 equity offerings.
- Common shares increased from 9,668,369 at December 31, 2021 to 14,966,739 at September 30, 2022, before considering potential dilution from warrants and options.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide quantitative revenue, earnings or margin guidance. Management states that the company has not established stabilized revenue sufficient to cover operating costs and remains dependent on increased sales and/or additional financing. The financial statements include a going-concern uncertainty, citing substantial historical losses and insufficient operating cash flows.
Management describes IvedaAI, IoT, smart power, Cerebro and Utilus smart-pole technologies as key areas of development. Taiwan remains strategically important; the filing states that Iveda Taiwan accounted for the majority of company revenue and represented 93% of total revenue in 2021.
On August 11, 2022, the company closed a private placement with approximately $5.0 million of gross proceeds before expenses. The transaction included common shares, pre-funded warrants and warrants exercisable for five and a half years at $1.40 per share. Net proceeds were intended for working capital and general corporate purposes. The company also completed an April 2022 equity offering; combined net proceeds from the 2022 offerings were approximately $11.5 million.
- Liquidity risk: operating cash burn may require additional equity or debt financing, potentially on unfavorable terms and with material dilution or senior securities.
- Customer concentration: two customers represented approximately 55% of nine-month revenue; Chunghwa Telecom represented approximately 34% and Chicony Power Technology approximately 21%.
- Geographic concentration: Taiwan generated $1.85 million of the $2.35 million of nine-month revenue, while the United States generated $0.50 million.
- Debt and related-party obligations include $0.30 million due to related parties, with the related debentures extended to December 31, 2022, and additional short-term and long-term bank debt.
- Accounts receivable are unsecured, and substantially all cash is held in a limited number of financial institutions, sometimes above applicable insurance limits.
- COVID-19, supply-chain or travel disruptions could delay projects, affect demand or impair the company’s ability to source, manufacture or deliver products, although management reported no material current disruption.
- A Taiwan subsidiary contingent exposure of approximately $0.29 million relates to required after-project services under certain contracts.
- No material legal proceedings were reported, and management concluded that disclosure controls and procedures were effective as of September 30, 2022.
Most Important Facts for Investors to Verify
- Whether the $10.56 million cash balance and equity proceeds are sufficient to fund operations given nine-month operating cash use of $3.30 million and continuing losses.
- Progress toward positive operating cash flow and whether revenue growth can offset rising operating expenses and declining gross margins.
- The composition, exercise prices, expiration dates and potential dilution from the 2022 warrants, pre-funded warrants, options and other convertible securities.
- Customer and Taiwan concentration, including the sustainability of the reported equipment-related revenue increase.
- The maturity, collateral and repayment status of short-term bank debt and related-party debentures.
- Whether the company can overcome the stated going-concern uncertainty without additional dilutive financing.
- The filing’s subsequent disclosures and any developments after November 14, 2022, including changes in liquidity, debt maturities, customer contracts or financing needs.